Novo Nordisk Sues Eli Lilly Over False GLP-1 Advertisements
What You Need to Know • Novo Nordisk filed a lawsuit against Eli Lilly on Tuesday for alleged false advertising ...
Tag: Novo
Novo Nordisk reduces Wegovy prices by 50% and Ozempic by 35%
Novo Nordisk announced it will reduce the prices of its weight-loss drugs Wegovy and Ozempic by up to 50%, effective ...
Novo Nordisk to reduce Wegovy list price by 50% in 2027
Novo Nordisk will reduce the U.S. list prices of its diabetes and weight-loss medications, Ozempic and Wegovy, by up to ...
Over 170,000 Americans use Wegovy, according to Novo Nordisk
Novo Nordisk reported strong demand for its Wegovy pill, which launched in the U.S. in January, with about 50,000 prescriptions ...
Current Value of Novo Nordisk Stock
The pharmaceutical sector is witnessing significant attention on GLP-1 weight-loss drugs, with Novo Nordisk (NYSE: NVO) initially leading the market. ...
Wegovy weight-loss pill launched by Novo Nordisk in the U.S.
A pill form of the weight-loss drug Wegovy, produced by Novo Nordisk, is now available in the U.S. at a ...
Reasons for Novo Nordisk Stock Increase Today
Shares of Novo Nordisk (NYSE: NVO) rose 3.5% on Monday, coinciding with gains in the S&P 500 and Nasdaq Composite. ...
Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country
Several applications for generic semaglutide, the active ingredient in Novo Nordisk's Ozempic and Wegovy, are currently under review by Health ...
Why Shares in Novo Nordisk Lost Weight Today
Shares of Denmark's pharmaceutical company Novo Nordisk (NYSE: NVO) fell by 4% following the termination of its partnership with telehealth ...
Novo Nordisk halts Wegovy sales on Hims & Hers, claiming “deceptive marketing” practices
Novo Nordisk has terminated its partnership with Hims & Hers Health due to allegations of the telehealth company selling counterfeit ...
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.